Biosecurity Modernization and Innovation Act of 2026
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 10
- Latest action
- Jan 29, 2026
What it does
The Biosecurity Modernization and Innovation Act of 2026 would require the Secretary of Commerce to establish regulations within one year of enactment to improve nucleic acid synthesis security, including mandatory screening of sequences and customer identity verification by covered providers such as synthetic nucleic acid sellers and equipment distributors. The bill would create a regularly updated list of sequences of concern, implement a conformity assessment system with audits and potential revocation of compliance status, and provide safeguards to avoid unnecessary burden on innovation, including exemptions for low-risk sequences and expedited review for accredited institutions. It…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.